Skip to the page

Data / Form D filings / Entopsis, Inc.

Entopsis, Inc.: Form D filings

Entopsis, Inc., a biotechnology company in Medley, FL, filed 4 Form D notices with the SEC between 2015 and 2023. The latest, on October 19, 2023, reports an offering of $6 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
7600 NW 69TH AVENUE, Medley, FL, 33166
Phone
(888) 407-5070
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1634457

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 19, 2023New notice$6,000,000$0$6,000,0000Yet to occursec.gov
Mar 1, 2021New notice$6,000,000$1,040,000$4,960,0009Feb 19, 2021sec.gov
Jan 10, 2017New notice$1,000,000$250,000$750,0002Dec 14, 2016sec.gov
Mar 19, 2015New notice$575,000$575,0005Sep 30, 2014sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Rohit BawaExecutive Officer
Obdulio PilotoExecutive Officer, Director
Chun Yi George HuangExecutive Officer, Director
Pratik SharmaExecutive Officer
Ian CheongExecutive Officer, Director

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Oct 16, 2023 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Entopsis, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.